Search - tctmd.com

Displaying 221 - 240 of 403

Sort: Relevancy | Date

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Yael L. Maxwell

February 24, 2022

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

L.A. McKeown

February 10, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Presenter: Sebastian Rosch

February 02, 2022

Presentation THT 2022

Left Ventricular Regional Functional Assessment for LIVE Therapy Using Inward Displacement

Presenter: Rishi Puri

February 02, 2022

Presentation THT 2022

Design and Rationale of the CORCINCH-HF pivotal study

Presenter: Ulrich Jorde

February 01, 2022

Presentation THT 2022

12-Month Outcomes for the AccuCinch System in HFrEF

Presenter: Nadira Hamid

February 01, 2022

Presentation THT 2022

From Access to Anchors: The AccuCinch Ventricular Restoration System

Presenter: Mohamed Latib

February 01, 2022

Presentation THT 2022

Reverse Remodeling in Heart Failure

Presenter: Daniel Burkhoff

February 01, 2022

Presentation THT 2022

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

Presenter: Kay Everett

February 01, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Michael O'Riordan

January 12, 2022

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Conference News PCR London Valves 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News AHA 2021

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Todd Neale

November 17, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

Advertisement

March 2022 News Roundup

AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Left Ventricular Regional Functional Assessment for LIVE Therapy Using Inward Displacement

Design and Rationale of the CORCINCH-HF pivotal study

12-Month Outcomes for the AccuCinch System in HFrEF

From Access to Anchors: The AccuCinch Ventricular Restoration System

Reverse Remodeling in Heart Failure

Combining VA-ECMO and Impella (EC-Pella) Before Reperfusion Mitigates Left Ventricular Loading and Injury Due to VA-ECMO In Acute Myocardial Infarction

February 2022 News Roundup

Using Donor Hearts After Circulatory Death Is Feasible for Transplantation

Women Less Likely Than Men to Experience SCD During Sports

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content